We have examined the effect of alpha-methylmannoside (alpha-MM) addition to concanavalin A (con A)-stimulated peripheral human lymphocytes. With a previously established kinetic model, we have, from the time course of proliferation, extracted the responding clone size, rate of entry of this clone into S phase and the length of the lag period. We have studied the effect of con A dose and time of addition of alpha-MM to optimally stimulated cells on these kinetic parameters. We show that neither a low dose of con A nor an early addition of alpha-MM to optimally stimulated cells results in a change in the responding clone size. This is, all of the potentially cells appears to become "committed" to enter the cell cycle regardless of the presence of alpha-MM early in the culture or in the presence of suboptimal stimulation. However, the rate at which these committed cells enter the first S phase is a function of the dose of con A and time of addition of alpha-MM and varies over a wide range. It is the variation in this parameter that accounts for virtually all of the diminished response previously interpreted as a time-dependent irreversible commitment of mitogen-stimulated cells. The previous work using only fixed time points for measuring thymidine uptake and the concept of commitment must be reevaluated in light of the kinetic evidence presented.
No takes yet. Share an insight, caveat, or question.
Hall et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Journal of Cellular Physiology